Discontinued — last reported Q4 '25
Business Segments · Restructuring expenses and asset impairments
HST — Restructuring expenses and asset impairments
Year-over-year, this metric declined by 84.6%, from $2.60M to $400.00K. Over 3 years (FY 2022 to FY 2025), HST — Restructuring expenses and asset impairments shows a downward trend with a -11.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025Feb 19, 2026
Rolls up toRestructuring and Asset Impairment Charges
How to read this metric
High levels suggest significant internal change or portfolio cleanup, which may temporarily depress earnings.
Detailed definition
The combined impact of operational reorganization costs and non-cash asset write-downs within the Health and Science Tec...
Peer comparison
Often used by analysts to adjust EBITDA to understand 'normalized' operating performance.
Metric ID:
iex_segment_hst_restructuring_expenses_and_asset_impairmentsHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00K | $100.00K | $17.20M | $600.00K | $300.00K | $2.70M | $1.50M | $2.10M | $500.00K | $1.10M | $1.70M | $2.60M | $11.40M | $700.00K | $0.00 | $400.00K |
| QoQ Change | — | +0.0% | >999% | -96.5% | -50.0% | +800.0% | -44.4% | +40.0% | -76.2% | +120.0% | +54.5% | +52.9% | +338.5% | -93.9% | -100.0% | — |
| YoY Change | — | — | — | — | +200.0% | >999% | -91.3% | +250.0% | +66.7% | -59.3% | +13.3% | +23.8% | >999% | -36.4% | -100.0% | -84.6% |
Range$0.00 – $17.20M
CAGR+44.7%
Avg YoY Growth+413.5%
Median YoY Growth+18.6%
Current Streak3 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IDEX's hst — restructuring expenses and asset impairments?
- IDEX (IEX) reported hst — restructuring expenses and asset impairments of $400.00K in Q4 2025.
- How has IDEX's hst — restructuring expenses and asset impairments changed year-over-year?
- IDEX's hst — restructuring expenses and asset impairments decreased by 84.6% year-over-year, from $2.60M to $400.00K.
- What is the long-term trend for IDEX's hst — restructuring expenses and asset impairments?
- Over 3 years (2022 to 2025), IDEX's hst — restructuring expenses and asset impairments has grown at a -11.4% compound annual growth rate (CAGR), from $18.00M to $12.50M.
- What does hst — restructuring expenses and asset impairments mean?
- The total financial impact of restructuring and asset value write-downs.